Lv2
180 积分 2023-10-30 加入
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
22天前
已完结
EGFR-mutated NSCLC: A roadmap to treatment sequences
22天前
已完结
Ivonescimab: First Approval
23天前
已完结
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
8个月前
已完结
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data
1年前
已完结
皖公网安备34019202002308
